<?xml version="1.0" encoding="UTF-8"?>
<p>In 7/11 tested patients with COVID-19–GBS, the virus was not detected in the CSF, implying no direct root infection or intrathecal viral replication. The improvement of several patients with IVIg and the presence of GD1b antibodies in 1 tested patient suggest a postviral-triggered immune response similar to other postviral-induced GBS cases
 <sup>
  <xref rid="R1" ref-type="bibr">1</xref>
  <xref ref-type="bibr" rid="R2">–</xref>
  <xref rid="R3" ref-type="bibr">3</xref>
 </sup> or other postviral autoimmune neurologic disorders.
 <sup>
  <xref rid="R14" ref-type="bibr">14</xref>
 </sup> The reported GD1b ganglioside antibodies, however, although in contrast to GQ1b antibodies typically seen in MFS, are of very special interest.
</p>
